FDA panel votes in support of authorizing Moderna booster
The independent FDA advisory panel on Thursday voted unanimously to authorize Moderna vaccine boosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus through work or home life.
The recommendation is in line with what the FDA and CDC authorized for Pfizer booster shots last month.
The FDA panel will meet on Friday on J&J boosters. Following next week's meetings from the CDC’s independent advisory group, Moderna and J&J boosters could be authorized and recommended for specific populations as soon as Oct. 22.
-ABC News' Sasha Pezenik, Cheyenne Haslett